NM_001080414.4:c.3895C>T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001080414.4(CCDC88C):​c.3895C>T​(p.Arg1299Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00666 in 1,613,446 control chromosomes in the GnomAD database, including 45 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1299P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0043 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0069 ( 44 hom. )

Consequence

CCDC88C
NM_001080414.4 missense

Scores

5
4
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:4

Conservation

PhyloP100: 3.94

Publications

15 publications found
Variant links:
Genes affected
CCDC88C (HGNC:19967): (coiled-coil domain containing 88C) This gene encodes a ubiquitously expressed coiled-coil domain-containing protein that interacts with the dishevelled protein and is a negative regulator of the Wnt signalling pathway. The protein encoded by this gene has a PDZ-domain binding motif in its C-terminus with which it interacts with the dishevelled protein. Dishevelled is a scaffold protein involved in the regulation of the Wnt signaling pathway. The Wnt signaling pathway plays an important role in embryonic development, tissue maintenance, and cancer progression. Mutations in this gene cause autosomal recessive, primary non-syndromic congenital hydrocephalus; a condition characterized by excessive accumulation of cerebrospinal fluid in the ventricles of the brain. [provided by RefSeq, Jan 2013]
CCDC88C Gene-Disease associations (from GenCC):
  • hydrocephalus, nonsyndromic, autosomal recessive 1
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • spinocerebellar ataxia type 40
    Inheritance: AD Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010968417).
BP6
Variant 14-91297376-G-A is Benign according to our data. Variant chr14-91297376-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 376774.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00426 (649/152340) while in subpopulation NFE AF = 0.00726 (494/68030). AF 95% confidence interval is 0.00673. There are 1 homozygotes in GnomAd4. There are 285 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 44 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC88CNM_001080414.4 linkc.3895C>T p.Arg1299Cys missense_variant Exon 22 of 30 ENST00000389857.11 NP_001073883.2 Q9P219-1B4DZB8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC88CENST00000389857.11 linkc.3895C>T p.Arg1299Cys missense_variant Exon 22 of 30 5 NM_001080414.4 ENSP00000374507.6 Q9P219-1

Frequencies

GnomAD3 genomes
AF:
0.00426
AC:
649
AN:
152222
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00113
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00242
Gnomad ASJ
AF:
0.00403
Gnomad EAS
AF:
0.00423
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00188
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00726
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00442
AC:
1095
AN:
247678
AF XY:
0.00469
show subpopulations
Gnomad AFR exome
AF:
0.00112
Gnomad AMR exome
AF:
0.00241
Gnomad ASJ exome
AF:
0.00340
Gnomad EAS exome
AF:
0.00418
Gnomad FIN exome
AF:
0.00246
Gnomad NFE exome
AF:
0.00661
Gnomad OTH exome
AF:
0.00548
GnomAD4 exome
AF:
0.00692
AC:
10104
AN:
1461106
Hom.:
44
Cov.:
33
AF XY:
0.00686
AC XY:
4988
AN XY:
726742
show subpopulations
African (AFR)
AF:
0.000837
AC:
28
AN:
33464
American (AMR)
AF:
0.00260
AC:
116
AN:
44622
Ashkenazi Jewish (ASJ)
AF:
0.00314
AC:
82
AN:
26100
East Asian (EAS)
AF:
0.00491
AC:
195
AN:
39694
South Asian (SAS)
AF:
0.00188
AC:
162
AN:
86072
European-Finnish (FIN)
AF:
0.00274
AC:
146
AN:
53356
Middle Eastern (MID)
AF:
0.00468
AC:
27
AN:
5768
European-Non Finnish (NFE)
AF:
0.00806
AC:
8959
AN:
1111670
Other (OTH)
AF:
0.00644
AC:
389
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
585
1170
1754
2339
2924
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
356
712
1068
1424
1780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00426
AC:
649
AN:
152340
Hom.:
1
Cov.:
33
AF XY:
0.00383
AC XY:
285
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00113
AC:
47
AN:
41584
American (AMR)
AF:
0.00242
AC:
37
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00403
AC:
14
AN:
3470
East Asian (EAS)
AF:
0.00424
AC:
22
AN:
5190
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4824
European-Finnish (FIN)
AF:
0.00188
AC:
20
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00726
AC:
494
AN:
68030
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
36
72
107
143
179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00609
Hom.:
14
Bravo
AF:
0.00436
TwinsUK
AF:
0.00701
AC:
26
ALSPAC
AF:
0.0117
AC:
45
ESP6500AA
AF:
0.00183
AC:
8
ESP6500EA
AF:
0.00725
AC:
62
ExAC
AF:
0.00449
AC:
544
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.00703
EpiControl
AF:
0.00647

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Jan 31, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 11, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CCDC88C: BP4, BS2 -

Intellectual disability Uncertain:1
Oct 17, 2019
Cambridge Genomics Laboratory, East Genomic Laboratory Hub, NHS Genomic Medicine Service
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epilepsy Uncertain:1
Oct 09, 2019
Cambridge Genomics Laboratory, East Genomic Laboratory Hub, NHS Genomic Medicine Service
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jul 24, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

CCDC88C-related disorder Benign:1
Aug 14, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.30
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.17
T
Eigen
Pathogenic
0.70
Eigen_PC
Pathogenic
0.67
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.93
D
M_CAP
Benign
0.026
D
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.8
M
PhyloP100
3.9
PrimateAI
Benign
0.39
T
PROVEAN
Pathogenic
-5.2
D
REVEL
Benign
0.19
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.0040
D
Polyphen
1.0
D
Vest4
0.60
MVP
0.67
MPC
0.55
ClinPred
0.030
T
GERP RS
5.3
Varity_R
0.52
gMVP
0.27
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142539336; hg19: chr14-91763720; COSMIC: COSV66235587; API